Rituximab (Rituxan) plus CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) is the standard induction therapy for patients with advanced-stage diffuse large B-cell lymphoma, including both elderly and younger patients.
Jerry Ingram
Advertisement
Articles by Jerry Ingram
For clinicians, MRI may offer a more in-depth view than mammography for planning surgery and screening for contralateral breast cancers, but does use of MRI actually benefit patients?
Advertisement
Latest Updated Articles
- R-CHOP is standard of care for advanced DLBCL patients
Published: November 1st 2007 | Updated:
- Preop MRI for breast cancer: Intuition no substitute for data
Published: November 1st 2007 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Cancer Vaccine/Pembrolizumab Improves PFS in Treatment-Naive Melanoma
2
FDA Issues CRL for Dasatinib in CML/ALL
3
Oral SERD Regimen May Prolong Efficacy in Second-Line Breast Cancer Care
4
Key Takeaways From IMS Real-World Data on Managing Step-Up Dosing in Relapsed/Refractory Multiple Myeloma
5
